Nemaura Medical Statistics
Total Valuation
NMRD has a market cap or net worth of $2.11 million. The enterprise value is $21.62 million.
| Market Cap | 2.11M |
| Enterprise Value | 21.62M |
Important Dates
The last earnings date was Friday, February 23, 2024, before market open.
| Earnings Date | Feb 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NMRD has 28.90 million shares outstanding. The number of shares has increased by 19.90% in one year.
| Shares Outstanding | 28.90M |
| Shares Change (YoY) | +19.90% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.62% |
| Owned by Institutions (%) | 4.41% |
| Float | 18.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1.88 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -121.81% |
| Return on Capital (ROIC) | -534.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$174,905 |
| Employee Count | 36 |
| Asset Turnover | -0.11 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | -946,868 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.54% in the last 52 weeks. The beta is -0.06, so NMRD's price volatility has been lower than the market average.
| Beta (1Y) | -0.06 |
| 52-Week Price Change | -91.54% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 43.01 |
| Average Volume (30 Days) | 37,501 |
Short Selling Information
The latest short interest is 52,568, so 0.18% of the outstanding shares have been sold short.
| Short Interest | 52,568 |
| Short Previous Month | 212,672 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, NMRD had revenue of -$1.55 million and -$6.30 million in losses. Loss per share was -$0.22.
| Revenue | -1.55M |
| Gross Profit | -4.58M |
| Operating Income | -9.71M |
| Pretax Income | -10.65M |
| Net Income | -6.30M |
| EBITDA | -7.59M |
| EBIT | -8.07M |
| Loss Per Share | -$0.22 |
Balance Sheet
The company has $137,416 in cash and $19.64 million in debt, giving a net cash position of -$19.51 million or -$0.67 per share.
| Cash & Cash Equivalents | 137,416 |
| Total Debt | 19.64M |
| Net Cash | -19.51M |
| Net Cash Per Share | -$0.67 |
| Equity / Book Value | -17.83M |
| Book Value Per Share | -0.62 |
| Working Capital | -18.62M |
Cash Flow
In the last 12 months, operating cash flow was -$9.57 million and capital expenditures -$177,219, giving a free cash flow of -$9.74 million.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -177,219 |
| Free Cash Flow | -9.74M |
| FCF Per Share | -$0.34 |
Margins
Gross margin is 295.15%, with operating and profit margins of 625.24% and 405.33%.
| Gross Margin | 295.15% |
| Operating Margin | 625.24% |
| Pretax Margin | 685.64% |
| Profit Margin | 405.33% |
| EBITDA Margin | 488.44% |
| EBIT Margin | 519.67% |
| FCF Margin | 627.16% |
Dividends & Yields
NMRD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.90% |
| Shareholder Yield | -19.90% |
| Earnings Yield | -298.46% |
| FCF Yield | -461.80% |
Analyst Forecast
The average price target for NMRD is $3.25, which is 4,352.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.25 |
| Price Target Difference | 4,352.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 5, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 5, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
NMRD has an Altman Z-Score of -25.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.39 |
| Piotroski F-Score | 1 |